Loading…

Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products

[Display omitted] •A stability indicating method for thiocolchicoside has been developed.•The method was validated as for ICH guidelines.•The method was used for the analyses of thiocolchicoside commercial liquid or solid dosage form samples. A stability indicating high performance liquid chromatogr...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis 2017-01, Vol.132, p.66-71
Main Authors: Aprile, Silvio, Canavesi, Rossana, Bianchi, Michele, Grosa, Giorgio, Del Grosso, Erika
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-e14dbbd67f2ce5c4cac339a8b97abd940afcb41e779d48b0743318dbb54cf7933
cites cdi_FETCH-LOGICAL-c356t-e14dbbd67f2ce5c4cac339a8b97abd940afcb41e779d48b0743318dbb54cf7933
container_end_page 71
container_issue
container_start_page 66
container_title Journal of pharmaceutical and biomedical analysis
container_volume 132
creator Aprile, Silvio
Canavesi, Rossana
Bianchi, Michele
Grosa, Giorgio
Del Grosso, Erika
description [Display omitted] •A stability indicating method for thiocolchicoside has been developed.•The method was validated as for ICH guidelines.•The method was used for the analyses of thiocolchicoside commercial liquid or solid dosage form samples. A stability indicating high performance liquid chromatography method has been developed for the determination of thiocolchicoside (TCC) and its main degradation products thiocolchicoside S-oxide (D1SO) and 3-O-demethylthiocolchicine (D3) in liquid and solid formulations. The method was developed based on a previous forced degradation study showing that TCC underwent chemical degradation by acid/base catalyzed hydrolysis and oxidation being the main degradation products D3 and D1SO respectively. The analytes separation and quantification were achieved on a Synergi™ 4μm Polar-RP 80Å, column 150×4.6mm (Phenomenex) using the mobile phase constituted (flow rate 1mLmin−1) of eluant A: 20mM sodium acetate buffer (pH 5.0) and eluant B: MeOH:CH3CN (20:80); the elution was performed in gradient mode detecting the analytes at 254nm. The method showed linearity for TCC assay in the 5–15μgmL−1, range and for unknown (TCCfu) and known (D1SO and D3) degradation products assay, in the 0.5–10μgmL−1 range: all the square of the correlation coefficients were greater than 0.999. The precision, determined in terms of intra-day and inter-day were expressed as RSDs and resulted to be 1.19, 1.10, 1.37 and 1.04% and 0.95, 0.83, 1.30 and 0.72 for TCC, TCCfu, D1SO and D3, respectively. The method demonstrated also to be accurate; indeed, the average recoveries were 102.1/102.0% for TCC (ampoules and hard capsules respectively), 101.3/100.3% for TCCfu, 101.7/100.2% for D1SO, and 101.4/101.4% for D3. The robustness was also evaluated by variations of mobile phase composition and pH. Finally, the applicability of the method was evaluated by analysis of commercial liquid and solid dosage forms.
doi_str_mv 10.1016/j.jpba.2016.09.037
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835354607</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708516307105</els_id><sourcerecordid>1835354607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e14dbbd67f2ce5c4cac339a8b97abd940afcb41e779d48b0743318dbb54cf7933</originalsourceid><addsrcrecordid>eNp9UctuEzEUtRCIpik_wAJ5yWYGe-wZjyU2KDyKFKks2oqd5cedxtHMONhOpP4CX12nCV2yule656F7DkLvKakpod2nbb3dGV03Za-JrAkTr9CC9oJVTcd_v0YLIhitBOnbC3SZ0pYQ0lLJ36KLRnRStIIu0N-vcIAx7CaYM9azwwc9eqezDzMOA9Y4ZW386PNj5WfnbbnMD_j613pV3d3jCfImODyEiPMGsIMMcfLzC_1244MNo914G5J38OzgcyrIh6jPNrsY3N7mdIXeDHpM8O48l-ju-7fb1XW1vvnxc_VlXVnWdrkCyp0xrhNDY6G13GrLmNS9kUIbJznRgzWcghDS8d4QwRmjfaG03A5CMrZEH0-6xfjPHlJWk08WxlHPEPZJ0Z61rOVdSW-JmhPUxpBShEHtop90fFSUqGMHaquOHahjB4pIVToopA9n_b2ZwL1Q_oVeAJ9PAChfHjxElayH2YLzEWxWLvj_6T8BeD-biw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835354607</pqid></control><display><type>article</type><title>Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Aprile, Silvio ; Canavesi, Rossana ; Bianchi, Michele ; Grosa, Giorgio ; Del Grosso, Erika</creator><creatorcontrib>Aprile, Silvio ; Canavesi, Rossana ; Bianchi, Michele ; Grosa, Giorgio ; Del Grosso, Erika</creatorcontrib><description>[Display omitted] •A stability indicating method for thiocolchicoside has been developed.•The method was validated as for ICH guidelines.•The method was used for the analyses of thiocolchicoside commercial liquid or solid dosage form samples. A stability indicating high performance liquid chromatography method has been developed for the determination of thiocolchicoside (TCC) and its main degradation products thiocolchicoside S-oxide (D1SO) and 3-O-demethylthiocolchicine (D3) in liquid and solid formulations. The method was developed based on a previous forced degradation study showing that TCC underwent chemical degradation by acid/base catalyzed hydrolysis and oxidation being the main degradation products D3 and D1SO respectively. The analytes separation and quantification were achieved on a Synergi™ 4μm Polar-RP 80Å, column 150×4.6mm (Phenomenex) using the mobile phase constituted (flow rate 1mLmin−1) of eluant A: 20mM sodium acetate buffer (pH 5.0) and eluant B: MeOH:CH3CN (20:80); the elution was performed in gradient mode detecting the analytes at 254nm. The method showed linearity for TCC assay in the 5–15μgmL−1, range and for unknown (TCCfu) and known (D1SO and D3) degradation products assay, in the 0.5–10μgmL−1 range: all the square of the correlation coefficients were greater than 0.999. The precision, determined in terms of intra-day and inter-day were expressed as RSDs and resulted to be 1.19, 1.10, 1.37 and 1.04% and 0.95, 0.83, 1.30 and 0.72 for TCC, TCCfu, D1SO and D3, respectively. The method demonstrated also to be accurate; indeed, the average recoveries were 102.1/102.0% for TCC (ampoules and hard capsules respectively), 101.3/100.3% for TCCfu, 101.7/100.2% for D1SO, and 101.4/101.4% for D3. The robustness was also evaluated by variations of mobile phase composition and pH. Finally, the applicability of the method was evaluated by analysis of commercial liquid and solid dosage forms.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/j.jpba.2016.09.037</identifier><identifier>PMID: 27697571</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Catalysis ; Chromatography, High Pressure Liquid - methods ; Colchicine - analogs &amp; derivatives ; Colchicine - analysis ; Degradation products ; Drug Stability ; HPLC-UV ; Hydrogen-Ion Concentration ; Hydrolysis ; Limit of Detection ; Linear Models ; Oxidation-Reduction ; Reproducibility of Results ; Stability indicating method ; Thiocolchicoside ; Ultraviolet Rays ; Validation</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2017-01, Vol.132, p.66-71</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e14dbbd67f2ce5c4cac339a8b97abd940afcb41e779d48b0743318dbb54cf7933</citedby><cites>FETCH-LOGICAL-c356t-e14dbbd67f2ce5c4cac339a8b97abd940afcb41e779d48b0743318dbb54cf7933</cites><orcidid>0000-0002-2398-5944</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27697571$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aprile, Silvio</creatorcontrib><creatorcontrib>Canavesi, Rossana</creatorcontrib><creatorcontrib>Bianchi, Michele</creatorcontrib><creatorcontrib>Grosa, Giorgio</creatorcontrib><creatorcontrib>Del Grosso, Erika</creatorcontrib><title>Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>[Display omitted] •A stability indicating method for thiocolchicoside has been developed.•The method was validated as for ICH guidelines.•The method was used for the analyses of thiocolchicoside commercial liquid or solid dosage form samples. A stability indicating high performance liquid chromatography method has been developed for the determination of thiocolchicoside (TCC) and its main degradation products thiocolchicoside S-oxide (D1SO) and 3-O-demethylthiocolchicine (D3) in liquid and solid formulations. The method was developed based on a previous forced degradation study showing that TCC underwent chemical degradation by acid/base catalyzed hydrolysis and oxidation being the main degradation products D3 and D1SO respectively. The analytes separation and quantification were achieved on a Synergi™ 4μm Polar-RP 80Å, column 150×4.6mm (Phenomenex) using the mobile phase constituted (flow rate 1mLmin−1) of eluant A: 20mM sodium acetate buffer (pH 5.0) and eluant B: MeOH:CH3CN (20:80); the elution was performed in gradient mode detecting the analytes at 254nm. The method showed linearity for TCC assay in the 5–15μgmL−1, range and for unknown (TCCfu) and known (D1SO and D3) degradation products assay, in the 0.5–10μgmL−1 range: all the square of the correlation coefficients were greater than 0.999. The precision, determined in terms of intra-day and inter-day were expressed as RSDs and resulted to be 1.19, 1.10, 1.37 and 1.04% and 0.95, 0.83, 1.30 and 0.72 for TCC, TCCfu, D1SO and D3, respectively. The method demonstrated also to be accurate; indeed, the average recoveries were 102.1/102.0% for TCC (ampoules and hard capsules respectively), 101.3/100.3% for TCCfu, 101.7/100.2% for D1SO, and 101.4/101.4% for D3. The robustness was also evaluated by variations of mobile phase composition and pH. Finally, the applicability of the method was evaluated by analysis of commercial liquid and solid dosage forms.</description><subject>Catalysis</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Colchicine - analogs &amp; derivatives</subject><subject>Colchicine - analysis</subject><subject>Degradation products</subject><subject>Drug Stability</subject><subject>HPLC-UV</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hydrolysis</subject><subject>Limit of Detection</subject><subject>Linear Models</subject><subject>Oxidation-Reduction</subject><subject>Reproducibility of Results</subject><subject>Stability indicating method</subject><subject>Thiocolchicoside</subject><subject>Ultraviolet Rays</subject><subject>Validation</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9UctuEzEUtRCIpik_wAJ5yWYGe-wZjyU2KDyKFKks2oqd5cedxtHMONhOpP4CX12nCV2yule656F7DkLvKakpod2nbb3dGV03Za-JrAkTr9CC9oJVTcd_v0YLIhitBOnbC3SZ0pYQ0lLJ36KLRnRStIIu0N-vcIAx7CaYM9azwwc9eqezDzMOA9Y4ZW386PNj5WfnbbnMD_j613pV3d3jCfImODyEiPMGsIMMcfLzC_1244MNo914G5J38OzgcyrIh6jPNrsY3N7mdIXeDHpM8O48l-ju-7fb1XW1vvnxc_VlXVnWdrkCyp0xrhNDY6G13GrLmNS9kUIbJznRgzWcghDS8d4QwRmjfaG03A5CMrZEH0-6xfjPHlJWk08WxlHPEPZJ0Z61rOVdSW-JmhPUxpBShEHtop90fFSUqGMHaquOHahjB4pIVToopA9n_b2ZwL1Q_oVeAJ9PAChfHjxElayH2YLzEWxWLvj_6T8BeD-biw</recordid><startdate>20170105</startdate><enddate>20170105</enddate><creator>Aprile, Silvio</creator><creator>Canavesi, Rossana</creator><creator>Bianchi, Michele</creator><creator>Grosa, Giorgio</creator><creator>Del Grosso, Erika</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2398-5944</orcidid></search><sort><creationdate>20170105</creationdate><title>Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products</title><author>Aprile, Silvio ; Canavesi, Rossana ; Bianchi, Michele ; Grosa, Giorgio ; Del Grosso, Erika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e14dbbd67f2ce5c4cac339a8b97abd940afcb41e779d48b0743318dbb54cf7933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Catalysis</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Colchicine - analogs &amp; derivatives</topic><topic>Colchicine - analysis</topic><topic>Degradation products</topic><topic>Drug Stability</topic><topic>HPLC-UV</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hydrolysis</topic><topic>Limit of Detection</topic><topic>Linear Models</topic><topic>Oxidation-Reduction</topic><topic>Reproducibility of Results</topic><topic>Stability indicating method</topic><topic>Thiocolchicoside</topic><topic>Ultraviolet Rays</topic><topic>Validation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aprile, Silvio</creatorcontrib><creatorcontrib>Canavesi, Rossana</creatorcontrib><creatorcontrib>Bianchi, Michele</creatorcontrib><creatorcontrib>Grosa, Giorgio</creatorcontrib><creatorcontrib>Del Grosso, Erika</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aprile, Silvio</au><au>Canavesi, Rossana</au><au>Bianchi, Michele</au><au>Grosa, Giorgio</au><au>Del Grosso, Erika</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2017-01-05</date><risdate>2017</risdate><volume>132</volume><spage>66</spage><epage>71</epage><pages>66-71</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><abstract>[Display omitted] •A stability indicating method for thiocolchicoside has been developed.•The method was validated as for ICH guidelines.•The method was used for the analyses of thiocolchicoside commercial liquid or solid dosage form samples. A stability indicating high performance liquid chromatography method has been developed for the determination of thiocolchicoside (TCC) and its main degradation products thiocolchicoside S-oxide (D1SO) and 3-O-demethylthiocolchicine (D3) in liquid and solid formulations. The method was developed based on a previous forced degradation study showing that TCC underwent chemical degradation by acid/base catalyzed hydrolysis and oxidation being the main degradation products D3 and D1SO respectively. The analytes separation and quantification were achieved on a Synergi™ 4μm Polar-RP 80Å, column 150×4.6mm (Phenomenex) using the mobile phase constituted (flow rate 1mLmin−1) of eluant A: 20mM sodium acetate buffer (pH 5.0) and eluant B: MeOH:CH3CN (20:80); the elution was performed in gradient mode detecting the analytes at 254nm. The method showed linearity for TCC assay in the 5–15μgmL−1, range and for unknown (TCCfu) and known (D1SO and D3) degradation products assay, in the 0.5–10μgmL−1 range: all the square of the correlation coefficients were greater than 0.999. The precision, determined in terms of intra-day and inter-day were expressed as RSDs and resulted to be 1.19, 1.10, 1.37 and 1.04% and 0.95, 0.83, 1.30 and 0.72 for TCC, TCCfu, D1SO and D3, respectively. The method demonstrated also to be accurate; indeed, the average recoveries were 102.1/102.0% for TCC (ampoules and hard capsules respectively), 101.3/100.3% for TCCfu, 101.7/100.2% for D1SO, and 101.4/101.4% for D3. The robustness was also evaluated by variations of mobile phase composition and pH. Finally, the applicability of the method was evaluated by analysis of commercial liquid and solid dosage forms.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>27697571</pmid><doi>10.1016/j.jpba.2016.09.037</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-2398-5944</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 2017-01, Vol.132, p.66-71
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_1835354607
source ScienceDirect Freedom Collection 2022-2024
subjects Catalysis
Chromatography, High Pressure Liquid - methods
Colchicine - analogs & derivatives
Colchicine - analysis
Degradation products
Drug Stability
HPLC-UV
Hydrogen-Ion Concentration
Hydrolysis
Limit of Detection
Linear Models
Oxidation-Reduction
Reproducibility of Results
Stability indicating method
Thiocolchicoside
Ultraviolet Rays
Validation
title Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T03%3A29%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20a%20stability-indicating%20HPLC-UV%20method%20for%20the%20determination%20of%20Thiocolchicoside%20and%20its%20degradation%20products&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Aprile,%20Silvio&rft.date=2017-01-05&rft.volume=132&rft.spage=66&rft.epage=71&rft.pages=66-71&rft.issn=0731-7085&rft.eissn=1873-264X&rft_id=info:doi/10.1016/j.jpba.2016.09.037&rft_dat=%3Cproquest_cross%3E1835354607%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-e14dbbd67f2ce5c4cac339a8b97abd940afcb41e779d48b0743318dbb54cf7933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835354607&rft_id=info:pmid/27697571&rfr_iscdi=true